original post: https://redd.it/14eb4jt

CEO of Oxford Cannabinoid Technologies Holdings Plc, Clarissa Sowemimo-Coker, talks through the 4 live drug programmes at the company and their development timelines.

u_Doceo-Group by Doceo-Group

[report | abuse]